Durable natural killer cell responses after heterologous two-dose Ebola vaccination

Natural killer (NK) cells are implicated among immune effectors after vaccination against viral pathogens, including Ebola virus. The two-dose heterologous Ebola virus vaccine regimen, adenovirus type 26.ZEBOV followed by modified vaccinia Ankara-BN-Filo (EBOVAC2 consortium, EU Innovative Medicines...

Full description

Saved in:
Bibliographic Details
Published in:NPJ Vaccines
Main Authors: Wagstaffe, Helen R., Susannini, Giada, Thiébaut, Rodolphe, Richert, Laura, Lévy, Yves, Bockstal, Viki, Stoop, Jeroen N., Luhn, Kerstin, Douoguih, Macaya, Riley, Eleanor M., Lacabaratz, Christine, Goodier, Martin R.
Format: Artigo
Language:Inglês
Published: Nature Publishing Group UK 2021
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7846750/
https://ncbi.nlm.nih.gov/pubmed/33514756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-021-00280-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items